|
|
General Summary |
|
81 |
J Licinio & R Lisman
|
Full Article (PDF)
|
|
Guest Editorial |
Cytokines in the brain: neuropathological aspects |
83 |
R Dantzer
|
Full Article (PDF)
|
|
News & Views |
Schizophrenia, tardive dyskinesia, and a D3 receptor gene variant: a new twist on dyskinesias? |
86 |
DV Jeste & JR Kelsoe
|
Abstract
Full Article (PDF)
|
|
Complex traits, complex answers |
89 |
D Gurwitz
|
Abstract
Full Article (PDF)
|
|
State Of The Art |
Inflammatory mechanisms in Alzheimer disease: the role of beta-amyloid/glial interactions |
91 |
JS Pachter
|
Abstract
Full Article (PDF)
|
|
Cytokines In The Brain |
Antigen presentation in the CNS |
96 |
K Frei & A Fontana
|
Full Article (PDF)
|
|
Interleukin 1 receptor antagonist gene expression in rat pituitary in the systemic inflammatory response syndrome: pathophysiological implications |
99 |
J Licinio & M-L Wong
|
Abstract
Full Article (PDF)
|
|
Mouse Moloney leukemia virus infects microglia but not neurons even though it induces motor neuron disease |
104 |
JF Zachary,
TV Baszler,
RA French & KW Kelley
|
Abstract
Full Article (PDF)
|
|
Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): possible involvement in neurodegenerative processes |
107 |
P Giraudon,
S Buart,
A Bernard & M-F Belin
|
Abstract
Full Article (PDF)
|
|
Neuropathogenesis of HIV-1 infection: interactions between interleukin-1 and transforming growth factor- 1 |
111 |
L Vitkovi
|
Abstract
Full Article (PDF)
|
|
Both soluble and membrane-associated TNF activate brain microvascular endothelium: relevance to multiple sclerosis |
113 |
D Burger,
J Lou,
J-M Dayer & GE Grau
|
Full Article (PDF)
|
|
The kinetics and regulation of the induction of type II nitric oxide synthase and nitric oxide in human fetal glial cell cultures |
117 |
M Ding & JE Merrill
|
Abstract
Full Article (PDF)
|
|
Cytokines and acute neurodegeneration |
120 |
NJ Rothwell
|
Full Article (PDF)
|
|
Regulation of ICE activity and ICE isoforms by LPS |
122 |
S Tingsborg,
M Ziólkowska,
M Zetterström,
H Hasanvan & T Bartfai
|
Abstract
Full Article (PDF)
|
|
Transgenic models to assess the pathogenic actions of cytokines in the central nervous system |
125 |
IL Campbell,
AK Stalder,
C-S Chiang,
R Bellinger,
CJ Heyser,
S Steffensen,
E Masliah,
HC Powell,
LH Gold,
SJ Henriksen & GR Siggins
|
Abstract
Full Article (PDF)
|
|
Glia-derived cytokines and the biogenesis of amyloid plaques in Alzheimers disease |
130 |
AJ Patel,
A Jen,
C Wickenden,
L-S Jen,
SM Gentleman & HAR de Silva
|
Full Article (PDF)
|
|
Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue |
133 |
MC Morganti-Kossman,
PM Lenzlinger,
V Hans,
P Stahel,
E Csuka,
E Ammann,
R Stocker,
O Trentz & T Kossmann
|
Abstract
Full Article (PDF)
|
|
Therapeutic applications of anti-cytokine strategies |
137 |
S Poole
|
Full Article (PDF)
|
|
Immediate Communications |
Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients |
139 |
VM Steen,
R Løvlie,
T MacEwan & RG McCreadie
|
Abstract
Full Article (PDF)
|
|
Normal isoform of amyloid protein (PrP) in brains of spawning salmon |
146 |
CJ Gibbs, Jr & CL Bolis
|
Abstract
Full Article (PDF)
|
|
Original Research Articles |
Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families |
148 |
RE Straub,
CJ MacLean,
FA ONeill,
D Walsh & KS Kendler
|
Abstract
Full Article (PDF)
|
|
Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis |
156 |
SG Schwab,
GN Eckstein,
J Hallmayer,
B Lerer,
M Albus,
M Borrmann,
D Lichtermann,
MA Ertl,
W Maier & DB Wildenauer
|
Abstract
Full Article (PDF)
|
|
Cannabinoid receptor gene (CNR1): association with IV drug use |
161 |
DE Comings,
D Muhleman,
R Gade,
P Johnson,
R Verde,
G Saucier & J MacMurray
|
Abstract
Full Article (PDF)
|
|
Association between the cannabinoid receptor gene (CNR1) and the P300 event-related potential |
169 |
JP Johnson,
D Muhleman,
J MacMurray,
R Gade,
R Verde,
M Ask,
J Kelley & DE Comings
|
Abstract
Full Article (PDF)
|
|